Looking to read the latest press release or want to see what conference Next Breath will be exhibiting at next? Check here for information on the latest news and happenings.
|Oct. 24, 2018||Good Medicine: Solutions for Sensitive Injectable Formulations
Presenting: Julie Suman, President of Next Breath, and Adam Shain, Director, Global Business Development, Injectables.
|Next Breath / Aptar Webinar|
|Nov. 6-8, 2018||E&L Europe 2018 Conference
Presenting: Debunking the Leachable Myths of Gamma Sterilization: A Migration Study of Steam Vs. Gamma
Speaker: Francois Billard, Director of Operations at Next Breath
|Nov. 27-30, 2018||PDA E&L Conference
|Dec. 2018||Drug Delivery to the Lung (DDL18)
Baltimore, Maryland – January 19, 2018. Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems, with a core focus on extractables and leachables.
Brazilian National Sanitary Surveillance Agency (ANVISA) Certifies Next Breath as a Center for In Vitro Pharmaceutical Equivalence
Baltimore, USA – March 28th, 2014 - Next Breath is pleased to announce that the Brazilian National Sanitary Surveillance Agency (ANVISA) has certified the company as a Center for Pharmaceutical Equivalence (EQFAR). As a result, Next Breath is now authorized to conduct Pharmaceutical Equivalence studies for Brazil. ANVISA performed a week-long comprehensive audit of Next Breath’s quality systems in November [...]